| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
133,430 |
123,531 |
$14.97M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
93,782 |
83,215 |
$12.62M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
33,720 |
23,780 |
$9.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
119,565 |
76,579 |
$8.55M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30,897 |
29,139 |
$5.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
29,128 |
25,131 |
$4.83M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46,587 |
31,556 |
$3.60M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
42,368 |
26,516 |
$2.95M |
| 81514 |
|
17,802 |
15,165 |
$2.70M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,628 |
9,126 |
$2.52M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
36,942 |
22,595 |
$2.49M |
| G0378 |
Hospital observation service, per hour |
20,915 |
8,955 |
$2.46M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,945 |
22,236 |
$2.29M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,584 |
8,050 |
$2.13M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
30,142 |
9,230 |
$2.13M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13,761 |
9,301 |
$1.94M |
| 96127 |
|
27,000 |
15,822 |
$1.92M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
27,447 |
17,809 |
$1.90M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
25,625 |
10,680 |
$1.84M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
29,371 |
19,713 |
$1.77M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,383 |
5,774 |
$1.66M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,464 |
16,333 |
$1.62M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,730 |
4,224 |
$1.49M |
| 59025 |
Fetal non-stress test |
16,898 |
8,455 |
$1.48M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
43,881 |
39,635 |
$1.33M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16,157 |
10,377 |
$1.15M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
7,224 |
6,612 |
$1.15M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
3,861 |
3,617 |
$1.14M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,777 |
8,414 |
$1.11M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
15,898 |
6,761 |
$1.10M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,674 |
4,610 |
$1.07M |
| 80053 |
Comprehensive metabolic panel |
102,983 |
83,830 |
$1.06M |
| 92551 |
|
24,259 |
15,053 |
$1.02M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
14,407 |
10,354 |
$998K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
640 |
518 |
$872K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,183 |
5,341 |
$858K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,233 |
1,950 |
$848K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
9,997 |
6,354 |
$838K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
43,885 |
39,639 |
$794K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,851 |
867 |
$753K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
1,094 |
611 |
$745K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,982 |
2,570 |
$721K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,586 |
2,287 |
$690K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,495 |
6,392 |
$682K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
25,168 |
23,717 |
$644K |
| 92552 |
|
11,287 |
7,047 |
$628K |
| 84443 |
Thyroid stimulating hormone (TSH) |
40,270 |
36,379 |
$627K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14,805 |
13,594 |
$609K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,258 |
1,069 |
$604K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
17,049 |
11,624 |
$590K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,231 |
973 |
$568K |
| 47562 |
|
250 |
193 |
$568K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
177,156 |
143,956 |
$565K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
22,376 |
20,489 |
$552K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,172 |
1,791 |
$531K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
13,647 |
7,295 |
$497K |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,410 |
3,013 |
$496K |
| 99215 |
Prolong outpt/office vis |
4,436 |
3,532 |
$457K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
59,107 |
50,387 |
$454K |
| 58661 |
|
224 |
166 |
$444K |
| 80061 |
Lipid panel |
29,340 |
27,063 |
$436K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
413 |
358 |
$418K |
| 93325 |
|
4,539 |
4,211 |
$400K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
63,301 |
55,746 |
$400K |
| 36415 |
Collection of venous blood by venipuncture |
159,773 |
138,847 |
$399K |
| 94010 |
|
2,772 |
2,505 |
$386K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
46,069 |
37,017 |
$370K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
6,278 |
4,340 |
$369K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,078 |
2,947 |
$356K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
589 |
541 |
$352K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
745 |
654 |
$352K |
| 93458 |
|
266 |
225 |
$347K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,239 |
1,904 |
$347K |
| 71046 |
Radiologic examination, chest; 2 views |
17,258 |
15,646 |
$346K |
| 97803 |
|
4,411 |
4,216 |
$344K |
| 84439 |
|
24,656 |
21,777 |
$335K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
546 |
390 |
$332K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
18,110 |
16,847 |
$328K |
| 82607 |
|
14,830 |
13,512 |
$325K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
31,545 |
27,722 |
$323K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
547 |
472 |
$315K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,875 |
7,450 |
$313K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,534 |
2,934 |
$300K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,980 |
2,179 |
$298K |
| 96415 |
|
1,251 |
820 |
$288K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
501 |
449 |
$287K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,641 |
1,782 |
$273K |
| 76770 |
|
1,720 |
1,543 |
$266K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
6,863 |
6,247 |
$264K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,130 |
2,731 |
$260K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,130 |
10,207 |
$251K |
| 86780 |
|
13,124 |
11,905 |
$243K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
20,594 |
18,895 |
$235K |
| 86850 |
|
10,790 |
9,328 |
$227K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,768 |
1,486 |
$225K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15,310 |
13,885 |
$216K |
| 70491 |
|
769 |
615 |
$207K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,621 |
2,021 |
$201K |
| 82728 |
|
13,151 |
11,790 |
$201K |
| 85027 |
|
28,591 |
24,655 |
$193K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,067 |
938 |
$190K |
| 70496 |
|
869 |
704 |
$190K |
| 87480 |
|
10,159 |
9,610 |
$182K |
| 76820 |
|
6,546 |
3,033 |
$178K |
| 52000 |
|
299 |
258 |
$173K |
| 95816 |
|
1,096 |
943 |
$173K |
| A0425 |
Ground mileage, per statute mile |
3,048 |
2,766 |
$170K |
| 93975 |
|
1,468 |
1,243 |
$169K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,192 |
3,840 |
$164K |
| 96367 |
|
3,088 |
1,899 |
$161K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,133 |
989 |
$161K |
| 87510 |
|
10,147 |
9,598 |
$154K |
| 93970 |
|
1,177 |
1,042 |
$153K |
| 86900 |
|
10,511 |
9,052 |
$150K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,463 |
883 |
$149K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
677 |
432 |
$149K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
729 |
645 |
$146K |
| 76642 |
|
1,412 |
1,200 |
$146K |
| 74018 |
|
4,278 |
3,796 |
$142K |
| 97802 |
|
1,741 |
1,650 |
$141K |
| 97113 |
|
2,018 |
588 |
$141K |
| 83540 |
|
15,879 |
14,341 |
$141K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
1,471 |
1,365 |
$140K |
| 43235 |
|
357 |
294 |
$140K |
| 87660 |
|
10,951 |
10,371 |
$136K |
| 87150 |
|
4,373 |
3,972 |
$135K |
| 71045 |
Radiologic examination, chest; single view |
24,381 |
21,451 |
$132K |
| 83970 |
|
4,617 |
4,182 |
$132K |
| 93017 |
|
1,631 |
1,330 |
$129K |
| 64615 |
|
563 |
459 |
$128K |
| 97162 |
|
3,031 |
2,582 |
$126K |
| 97010 |
|
3,401 |
1,160 |
$125K |
| 83655 |
|
7,093 |
6,582 |
$124K |
| J9271 |
Injection, pembrolizumab, 1 mg |
22 |
15 |
$124K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,971 |
2,711 |
$124K |
| 76801 |
|
3,645 |
2,704 |
$123K |
| 97161 |
|
2,381 |
2,157 |
$120K |
| 72141 |
|
777 |
668 |
$118K |
| 64483 |
|
256 |
234 |
$118K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
42,368 |
37,988 |
$116K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,707 |
1,157 |
$115K |
| 12001 |
|
742 |
660 |
$114K |
| 94060 |
|
1,025 |
915 |
$112K |
| 75574 |
|
474 |
410 |
$110K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
1,087 |
1,021 |
$108K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
505 |
388 |
$108K |
| 76536 |
|
1,030 |
945 |
$105K |
| 80076 |
|
9,400 |
7,911 |
$104K |
| 84484 |
|
34,640 |
28,617 |
$102K |
| 83550 |
|
13,119 |
11,768 |
$102K |
| 99381 |
|
2,680 |
2,456 |
$101K |
| 58571 |
|
32 |
27 |
$97K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
81 |
49 |
$94K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
105 |
96 |
$93K |
| 74183 |
|
491 |
422 |
$93K |
| 84702 |
|
6,068 |
4,317 |
$92K |
| 76830 |
Ultrasound, transvaginal |
2,511 |
2,125 |
$91K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
956 |
738 |
$91K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
432 |
294 |
$90K |
| 87507 |
|
951 |
833 |
$90K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
31,824 |
22,145 |
$89K |
| 12011 |
|
584 |
537 |
$88K |
| 99177 |
|
10,409 |
9,699 |
$87K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
17,641 |
15,253 |
$87K |
| 92567 |
|
2,809 |
2,312 |
$85K |
| 86140 |
|
9,472 |
8,327 |
$85K |
| 90686 |
|
12,668 |
11,377 |
$84K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,338 |
603 |
$83K |
| 73562 |
|
4,250 |
3,381 |
$83K |
| 71250 |
|
987 |
886 |
$83K |
| 82570 |
|
10,052 |
8,755 |
$82K |
| 97166 |
|
1,476 |
1,216 |
$80K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
5,022 |
3,386 |
$80K |
| 86803 |
|
5,883 |
5,237 |
$79K |
| 86762 |
|
4,999 |
4,539 |
$77K |
| 76825 |
|
1,121 |
791 |
$77K |
| 83735 |
|
26,261 |
17,265 |
$77K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,877 |
6,005 |
$76K |
| 74240 |
|
521 |
482 |
$75K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,947 |
2,678 |
$75K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28,044 |
21,198 |
$73K |
| 87340 |
|
6,066 |
5,430 |
$72K |
| 10060 |
|
465 |
410 |
$72K |
| 72100 |
|
2,621 |
2,334 |
$72K |
| 82746 |
|
6,906 |
6,249 |
$69K |
| 36430 |
|
609 |
404 |
$69K |
| 74174 |
|
598 |
478 |
$67K |
| 80074 |
|
3,329 |
2,894 |
$67K |
| 93971 |
|
812 |
706 |
$66K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,500 |
1,297 |
$66K |
| 70486 |
|
1,218 |
1,025 |
$65K |
| 94726 |
|
1,470 |
1,283 |
$64K |
| 71271 |
|
466 |
414 |
$64K |
| 77336 |
|
600 |
249 |
$63K |
| 95819 |
|
358 |
345 |
$62K |
| 77300 |
|
124 |
102 |
$62K |
| 73610 |
|
3,086 |
2,583 |
$60K |
| 59430 |
|
586 |
476 |
$60K |
| 92588 |
|
531 |
447 |
$60K |
| 94619 |
|
510 |
438 |
$60K |
| 72110 |
|
1,046 |
964 |
$59K |
| 92557 |
|
781 |
703 |
$59K |
| 87077 |
|
8,617 |
7,623 |
$58K |
| 77334 |
|
230 |
148 |
$58K |
| 86787 |
|
3,536 |
3,210 |
$58K |
| 90670 |
|
9,416 |
8,462 |
$58K |
| 73030 |
|
2,881 |
2,436 |
$58K |
| 73221 |
|
310 |
269 |
$57K |
| 87081 |
|
4,313 |
3,915 |
$56K |
| 72040 |
|
1,417 |
1,251 |
$56K |
| 86901 |
|
10,458 |
9,003 |
$56K |
| 81001 |
|
14,354 |
12,657 |
$55K |
| 84481 |
|
3,863 |
3,538 |
$54K |
| D7140 |
Extraction, erupted tooth or exposed root |
88 |
83 |
$54K |
| 77290 |
|
94 |
72 |
$53K |
| 99188 |
|
2,719 |
2,384 |
$52K |
| 95811 |
|
105 |
85 |
$51K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,403 |
2,829 |
$50K |
| 70498 |
|
975 |
786 |
$50K |
| 73630 |
|
3,228 |
2,714 |
$49K |
| 88307 |
|
650 |
507 |
$49K |
| 93225 |
|
551 |
503 |
$49K |
| 93880 |
|
652 |
578 |
$49K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
14 |
12 |
$48K |
| 86038 |
|
2,447 |
2,205 |
$48K |
| 72197 |
|
199 |
173 |
$48K |
| 90710 |
|
7,750 |
6,997 |
$47K |
| 76818 |
|
701 |
397 |
$47K |
| 94762 |
|
834 |
724 |
$46K |
| 90651 |
|
6,182 |
5,407 |
$46K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,082 |
2,815 |
$46K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
317 |
289 |
$46K |
| 73502 |
|
1,884 |
1,654 |
$45K |
| 86003 |
|
1,722 |
1,526 |
$45K |
| 92523 |
|
788 |
694 |
$45K |
| 87186 |
|
6,352 |
5,619 |
$44K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,953 |
4,528 |
$44K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,468 |
1,392 |
$44K |
| 93923 |
|
627 |
564 |
$44K |
| 99460 |
|
585 |
574 |
$43K |
| 93308 |
|
167 |
147 |
$43K |
| 83525 |
|
2,000 |
1,848 |
$42K |
| 88348 |
|
419 |
371 |
$42K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,207 |
1,991 |
$41K |
| 73700 |
|
385 |
314 |
$40K |
| 82950 |
|
4,191 |
3,815 |
$40K |
| 90715 |
|
4,319 |
3,666 |
$39K |
| 92526 |
|
654 |
288 |
$39K |
| 86480 |
|
991 |
901 |
$39K |
| 78800 |
|
51 |
51 |
$39K |
| 12002 |
|
277 |
254 |
$39K |
| 76813 |
|
833 |
437 |
$39K |
| 95700 |
|
306 |
262 |
$38K |
| 74230 |
|
373 |
333 |
$38K |
| 86592 |
|
1,069 |
927 |
$38K |
| 97116 |
|
1,748 |
925 |
$38K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
193 |
190 |
$38K |
| 81003 |
|
63,635 |
57,224 |
$37K |
| 86800 |
|
1,382 |
1,253 |
$37K |
| 82670 |
|
1,539 |
1,379 |
$36K |
| 36591 |
|
3,411 |
1,449 |
$36K |
| 94772 |
|
246 |
203 |
$36K |
| 85610 |
|
21,839 |
15,173 |
$36K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
50 |
45 |
$35K |
| 82043 |
|
5,385 |
4,993 |
$35K |
| 73130 |
|
2,701 |
2,169 |
$35K |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
197 |
66 |
$35K |
| 72050 |
|
594 |
524 |
$34K |
| 84403 |
|
2,101 |
1,905 |
$34K |
| 52356 |
|
19 |
14 |
$33K |
| 73564 |
|
692 |
507 |
$32K |
| 85652 |
|
7,719 |
6,893 |
$32K |
| 72120 |
|
556 |
501 |
$32K |
| 73110 |
|
1,773 |
1,435 |
$32K |
| 84153 |
|
2,180 |
1,992 |
$32K |
| 82784 |
|
2,516 |
2,179 |
$32K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
345 |
314 |
$31K |
| 76886 |
|
292 |
255 |
$31K |
| 87529 |
|
889 |
786 |
$31K |
| 86696 |
|
1,044 |
943 |
$30K |
| 77062 |
|
826 |
740 |
$30K |
| 87070 |
|
3,773 |
3,334 |
$30K |
| 94729 |
|
476 |
428 |
$29K |
| 95806 |
|
72 |
69 |
$29K |
| 86364 |
|
1,304 |
1,183 |
$28K |
| 77080 |
|
524 |
479 |
$28K |
| 99078 |
|
1,007 |
585 |
$28K |
| 95885 |
|
106 |
103 |
$27K |
| 87522 |
Neg quan hep c or qual rna |
775 |
683 |
$27K |
| 84146 |
|
1,839 |
1,630 |
$26K |
| 72158 |
|
170 |
142 |
$26K |
| 72072 |
|
943 |
846 |
$25K |
| 72131 |
|
615 |
510 |
$25K |
| 86706 |
|
1,505 |
1,347 |
$25K |
| 88184 |
|
395 |
315 |
$25K |
| 82565 |
|
5,026 |
3,956 |
$25K |
| 83001 |
|
1,523 |
1,391 |
$25K |
| 77049 |
|
66 |
60 |
$25K |
| 82785 |
|
1,622 |
1,433 |
$24K |
| 20680 |
|
22 |
14 |
$24K |
| 82105 |
|
1,575 |
1,392 |
$24K |
| 92652 |
|
566 |
479 |
$24K |
| 86235 |
|
1,536 |
685 |
$24K |
| 19083 |
|
28 |
25 |
$24K |
| 82248 |
|
2,520 |
2,077 |
$24K |
| 97533 |
|
395 |
236 |
$23K |
| 81025 |
|
43,337 |
38,286 |
$23K |
| 86704 |
|
895 |
793 |
$23K |
| 97163 |
|
455 |
399 |
$23K |
| 0012A |
|
633 |
585 |
$22K |
| 72156 |
|
177 |
149 |
$22K |
| 86376 |
|
1,467 |
1,333 |
$22K |
| 73590 |
|
1,423 |
1,123 |
$22K |
| 97165 |
|
331 |
298 |
$22K |
| 87493 |
|
805 |
710 |
$22K |
| 93304 |
|
70 |
67 |
$21K |
| 76870 |
|
517 |
453 |
$21K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
19 |
14 |
$21K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
209 |
204 |
$20K |
| 76882 |
|
237 |
200 |
$20K |
| 86431 |
|
1,474 |
1,323 |
$20K |
| 86200 |
|
731 |
652 |
$19K |
| 78264 |
|
92 |
82 |
$19K |
| 87205 |
|
3,291 |
2,880 |
$19K |
| 58558 |
|
17 |
13 |
$19K |
| 96376 |
|
11,576 |
5,211 |
$19K |
| 77065 |
Tomosynthesis, mammo |
821 |
708 |
$19K |
| 96368 |
|
1,220 |
670 |
$18K |
| 82533 |
|
939 |
780 |
$18K |
| 84425 |
|
1,665 |
1,547 |
$18K |
| 83020 |
|
1,538 |
1,361 |
$18K |
| 88341 |
|
355 |
310 |
$18K |
| 84100 |
|
5,845 |
3,945 |
$18K |
| 99222 |
Initial hospital care, per day, moderate complexity |
342 |
324 |
$18K |
| 95714 |
|
33 |
14 |
$17K |
| J3490 |
Unclassified drugs |
1,919 |
1,656 |
$17K |
| 82310 |
|
1,622 |
1,465 |
$17K |
| 92579 |
|
313 |
271 |
$17K |
| 73560 |
|
573 |
451 |
$17K |
| 82525 |
|
1,085 |
998 |
$17K |
| 92611 |
|
365 |
327 |
$16K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
309 |
301 |
$16K |
| 84590 |
|
835 |
782 |
$16K |
| 95911 |
|
60 |
53 |
$16K |
| H1000 |
Prenatal care, at-risk assessment |
663 |
507 |
$16K |
| 0011A |
|
741 |
646 |
$16K |
| 86870 |
|
499 |
394 |
$15K |
| 84156 |
|
4,468 |
3,600 |
$15K |
| 83002 |
|
1,087 |
983 |
$15K |
| 99243 |
|
515 |
465 |
$15K |
| 77061 |
|
379 |
337 |
$15K |
| 73552 |
|
800 |
680 |
$15K |
| 83690 |
|
19,720 |
16,398 |
$15K |
| 54150 |
|
291 |
282 |
$14K |
| 83880 |
|
3,964 |
3,261 |
$14K |
| 77072 |
|
197 |
181 |
$14K |
| 86695 |
|
1,004 |
903 |
$14K |
| 83021 |
|
1,041 |
962 |
$14K |
| 90677 |
|
1,731 |
1,620 |
$14K |
| 72081 |
|
245 |
229 |
$14K |
| 87631 |
|
214 |
212 |
$14K |
| 82951 |
|
681 |
612 |
$14K |
| 64643 |
|
25 |
13 |
$14K |
| 86147 |
|
435 |
373 |
$13K |
| 84550 |
|
3,452 |
2,818 |
$13K |
| 82627 |
|
512 |
464 |
$13K |
| 85014 |
|
4,904 |
3,760 |
$13K |
| 54161 |
|
25 |
18 |
$13K |
| 88185 |
|
385 |
311 |
$13K |
| 85246 |
|
645 |
564 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,723 |
2,525 |
$13K |
| 82550 |
|
2,377 |
1,825 |
$13K |
| 73080 |
|
1,099 |
936 |
$13K |
| 81596 |
|
120 |
104 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
461 |
450 |
$13K |
| 77066 |
Tomosynthesis, mammo |
965 |
860 |
$13K |
| 70544 |
|
71 |
65 |
$12K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
419 |
379 |
$12K |
| 99383 |
|
220 |
169 |
$12K |
| 86225 |
|
451 |
396 |
$12K |
| 0002A |
|
334 |
329 |
$12K |
| 84402 |
|
768 |
694 |
$12K |
| 80323 |
|
516 |
471 |
$12K |
| 85730 |
|
7,472 |
6,254 |
$11K |
| 83993 |
|
726 |
653 |
$11K |
| 84630 |
|
1,023 |
950 |
$11K |
| 83615 |
|
2,943 |
2,324 |
$11K |
| 0001A |
|
370 |
347 |
$11K |
| 97012 |
|
435 |
145 |
$11K |
| 73090 |
|
954 |
797 |
$11K |
| 43248 |
|
42 |
37 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
739 |
681 |
$11K |
| 59812 |
|
13 |
12 |
$11K |
| 72146 |
|
133 |
113 |
$11K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,231 |
1,004 |
$10K |
| 99152 |
|
858 |
762 |
$10K |
| 86160 |
|
838 |
735 |
$10K |
| 90620 |
|
1,566 |
1,370 |
$10K |
| 85576 |
|
547 |
478 |
$10K |
| 83013 |
|
204 |
179 |
$10K |
| 82947 |
|
2,435 |
2,005 |
$10K |
| 88342 |
|
988 |
841 |
$9K |
| 84144 |
|
403 |
347 |
$9K |
| 87102 |
|
851 |
753 |
$9K |
| 73140 |
|
552 |
483 |
$9K |
| 85379 |
|
6,496 |
5,558 |
$9K |
| 77280 |
|
60 |
48 |
$9K |
| 77301 |
|
13 |
12 |
$9K |
| 11045 |
|
47 |
24 |
$9K |
| 72128 |
|
273 |
207 |
$9K |
| 85018 |
|
5,321 |
4,089 |
$9K |
| 83520 |
|
403 |
377 |
$9K |
| 86705 |
|
313 |
293 |
$9K |
| 58300 |
|
103 |
86 |
$8K |
| 85397 |
|
598 |
509 |
$8K |
| 59514 |
|
12 |
12 |
$8K |
| 86735 |
|
227 |
217 |
$8K |
| 70360 |
|
264 |
221 |
$8K |
| 95886 |
|
28 |
27 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,294 |
1,152 |
$7K |
| 82952 |
|
579 |
521 |
$7K |
| 71101 |
|
577 |
511 |
$7K |
| 0071A |
|
174 |
171 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
127 |
113 |
$7K |
| 82024 |
|
277 |
223 |
$7K |
| 96523 |
|
186 |
126 |
$7K |
| 99462 |
|
202 |
142 |
$7K |
| 99205 |
Prolong outpt/office vis |
97 |
96 |
$7K |
| 82150 |
|
3,539 |
3,000 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,654 |
7,030 |
$6K |
| 84132 |
|
3,253 |
2,105 |
$6K |
| 81229 |
|
26 |
25 |
$6K |
| 92587 |
|
56 |
54 |
$6K |
| 84270 |
|
477 |
424 |
$6K |
| 84165 |
|
771 |
660 |
$6K |
| 73000 |
|
166 |
134 |
$6K |
| 88142 |
|
336 |
303 |
$6K |
| 72170 |
|
975 |
857 |
$6K |
| 82247 |
|
2,088 |
1,673 |
$6K |
| 76857 |
|
68 |
58 |
$6K |
| 84460 |
|
2,636 |
2,323 |
$6K |
| 85045 |
|
2,490 |
1,778 |
$6K |
| 99173 |
|
2,892 |
2,799 |
$6K |
| 84681 |
|
393 |
365 |
$6K |
| 86334 |
|
467 |
385 |
$6K |
| 87206 |
|
844 |
751 |
$6K |
| 82977 |
|
2,261 |
1,878 |
$6K |
| 86304 |
|
362 |
261 |
$5K |
| 84305 |
|
229 |
213 |
$5K |
| 73521 |
|
96 |
90 |
$5K |
| 84445 |
|
143 |
135 |
$5K |
| 86146 |
|
373 |
320 |
$5K |
| 90461 |
|
23,779 |
21,516 |
$5K |
| 83521 |
|
459 |
385 |
$5K |
| 25605 |
|
13 |
13 |
$5K |
| 93312 |
|
30 |
26 |
$5K |
| 84410 |
|
134 |
118 |
$5K |
| 73060 |
|
465 |
386 |
$5K |
| 94664 |
|
3,382 |
2,829 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
283 |
255 |
$5K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
32 |
17 |
$5K |
| 93320 |
|
3,892 |
3,637 |
$5K |
| 80197 |
|
369 |
192 |
$5K |
| 73523 |
|
115 |
108 |
$5K |
| 86765 |
|
260 |
244 |
$5K |
| 99153 |
Mod sedat endo service >5yrs |
642 |
568 |
$5K |
| 74019 |
|
1,009 |
912 |
$4K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
68 |
25 |
$4K |
| 83605 |
|
6,260 |
5,019 |
$4K |
| 87563 |
|
116 |
113 |
$4K |
| 74420 |
|
37 |
27 |
$4K |
| 92610 |
|
180 |
147 |
$4K |
| 88112 |
|
520 |
450 |
$4K |
| 82378 |
|
557 |
372 |
$4K |
| 80051 |
|
1,893 |
1,450 |
$4K |
| 84154 |
|
224 |
212 |
$4K |
| 0072A |
|
106 |
105 |
$4K |
| 88304 |
|
836 |
691 |
$4K |
| 83721 |
|
331 |
302 |
$4K |
| 80164 |
|
297 |
254 |
$4K |
| 84703 |
|
824 |
722 |
$4K |
| 86920 |
|
174 |
109 |
$4K |
| 82040 |
|
2,107 |
1,818 |
$4K |
| 85048 |
|
658 |
361 |
$4K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
68 |
65 |
$3K |
| 84450 |
|
2,016 |
1,748 |
$3K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
551 |
457 |
$3K |
| 87040 |
|
2,432 |
1,991 |
$3K |
| 83516 |
|
206 |
185 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
109 |
106 |
$3K |
| 77338 |
|
14 |
13 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
333 |
297 |
$3K |
| 82330 |
|
689 |
417 |
$3K |
| 85049 |
|
1,380 |
812 |
$3K |
| 78227 |
|
16 |
13 |
$3K |
| 87210 |
|
1,423 |
1,303 |
$3K |
| 0124A |
|
80 |
64 |
$3K |
| 73100 |
|
145 |
107 |
$3K |
| 86665 |
|
174 |
161 |
$3K |
| 99221 |
|
82 |
78 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,116 |
1,085 |
$3K |
| 99384 |
|
44 |
24 |
$3K |
| 81015 |
|
522 |
468 |
$3K |
| 83498 |
|
160 |
150 |
$3K |
| 74022 |
|
317 |
274 |
$3K |
| 84145 |
|
1,363 |
1,094 |
$3K |
| 85240 |
|
639 |
556 |
$3K |
| 86036 |
|
211 |
187 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$3K |
| 74178 |
|
15 |
15 |
$3K |
| 99382 |
|
51 |
38 |
$3K |
| 82077 |
|
3,525 |
2,898 |
$3K |
| 99458 |
|
124 |
53 |
$3K |
| 80354 |
|
313 |
290 |
$3K |
| 80177 |
|
421 |
357 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
61 |
24 |
$3K |
| J9045 |
Injection, carboplatin, 50 mg |
136 |
54 |
$2K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
13 |
13 |
$2K |
| 58100 |
|
12 |
12 |
$2K |
| 84520 |
|
2,149 |
1,709 |
$2K |
| 84134 |
|
217 |
179 |
$2K |
| 76826 |
|
50 |
38 |
$2K |
| 97750 |
|
61 |
53 |
$2K |
| 82103 |
|
154 |
137 |
$2K |
| 85613 |
|
317 |
268 |
$2K |
| 97167 |
|
54 |
51 |
$2K |
| 83921 |
|
231 |
203 |
$2K |
| 86255 |
|
166 |
151 |
$2K |
| 99242 |
|
124 |
100 |
$2K |
| C2629 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser |
413 |
357 |
$2K |
| 82140 |
|
497 |
393 |
$2K |
| 87641 |
|
100 |
97 |
$2K |
| 95251 |
|
100 |
97 |
$2K |
| 96417 |
|
825 |
409 |
$2K |
| A9270 |
Non-covered item or service |
1,032 |
687 |
$2K |
| 86308 |
|
334 |
288 |
$2K |
| 93702 |
|
12 |
12 |
$2K |
| 29515 |
|
252 |
232 |
$2K |
| 11043 |
|
28 |
25 |
$2K |
| 80047 |
|
3,477 |
2,919 |
$2K |
| 86039 |
|
201 |
192 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
137 |
80 |
$2K |
| 87486 |
|
209 |
204 |
$2K |
| 86341 |
|
76 |
68 |
$2K |
| 84207 |
|
168 |
150 |
$2K |
| 86355 |
|
47 |
38 |
$2K |
| 0154A |
|
41 |
30 |
$2K |
| 89051 |
|
592 |
453 |
$2K |
| C1769 |
Guide wire |
2,834 |
2,300 |
$2K |
| 86360 |
|
58 |
49 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
16 |
16 |
$2K |
| 99442 |
|
44 |
42 |
$1K |
| 99464 |
|
24 |
24 |
$1K |
| 64642 |
|
41 |
28 |
$1K |
| 86923 |
|
79 |
59 |
$1K |
| 97804 |
|
15 |
13 |
$1K |
| 73070 |
|
83 |
63 |
$1K |
| 80175 |
|
133 |
114 |
$1K |
| 85384 |
|
1,061 |
914 |
$1K |
| 98968 |
|
36 |
27 |
$1K |
| 87581 |
|
209 |
204 |
$1K |
| 82803 |
|
1,328 |
1,099 |
$1K |
| 86317 |
|
108 |
77 |
$1K |
| 87338 |
|
59 |
52 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
14 |
14 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,270 |
6,947 |
$1K |
| 0064A |
|
31 |
31 |
$1K |
| 85245 |
|
80 |
76 |
$1K |
| 99385 |
|
27 |
24 |
$1K |
| 99252 |
|
43 |
37 |
$1K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
27 |
25 |
$1K |
| 86015 |
|
58 |
54 |
$1K |
| 90656 |
|
112 |
111 |
$1K |
| 86359 |
|
47 |
38 |
$1K |
| 86357 |
|
47 |
38 |
$1K |
| 99245 |
|
12 |
12 |
$1K |
| 82010 |
|
994 |
765 |
$1K |
| 99457 |
|
74 |
55 |
$1K |
| 86880 |
|
53 |
37 |
$1K |
| 0031A |
|
39 |
39 |
$1K |
| 84432 |
|
58 |
54 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
7,321 |
6,194 |
$1K |
| 77002 |
|
16 |
14 |
$1K |
| 29125 |
|
369 |
332 |
$1K |
| 84075 |
|
1,739 |
1,486 |
$1K |
| 97016 |
|
28 |
12 |
$970.13 |
| 95711 |
|
29 |
25 |
$943.15 |
| 76937 |
|
95 |
80 |
$931.64 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19,977 |
16,470 |
$913.61 |
| 83874 |
|
612 |
502 |
$892.17 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
5,143 |
4,568 |
$858.83 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
219 |
202 |
$849.60 |
| 87503 |
|
53 |
53 |
$825.16 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
62 |
62 |
$802.73 |
| 80143 |
|
915 |
757 |
$785.00 |
| 99386 |
|
13 |
12 |
$733.18 |
| 87116 |
|
137 |
104 |
$705.26 |
| 99454 |
|
37 |
28 |
$696.01 |
| 88360 |
|
13 |
12 |
$676.59 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,259 |
704 |
$621.22 |
| 0054A |
|
14 |
13 |
$608.29 |
| 86231 |
|
17 |
12 |
$527.51 |
| J2785 |
Injection, regadenoson, 0.1 mg |
887 |
686 |
$526.90 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,061 |
2,341 |
$509.58 |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,741 |
2,783 |
$504.97 |
| 81050 |
|
88 |
78 |
$474.29 |
| 72157 |
|
13 |
13 |
$461.50 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
380 |
274 |
$452.81 |
| 81002 |
|
2,766 |
2,510 |
$451.10 |
| 86008 |
|
20 |
17 |
$444.17 |
| 86301 |
|
30 |
24 |
$427.02 |
| 86708 |
|
33 |
32 |
$418.48 |
| 82088 |
|
20 |
13 |
$411.18 |
| 87634 |
|
512 |
454 |
$361.24 |
| 83835 |
|
20 |
16 |
$360.95 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,081 |
694 |
$359.96 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
675 |
477 |
$354.22 |
| G0008 |
Administration of influenza virus vaccine |
42 |
41 |
$353.65 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,580 |
1,333 |
$347.78 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
188 |
166 |
$329.93 |
| 82397 |
|
15 |
15 |
$322.51 |
| 82955 |
|
16 |
12 |
$318.63 |
| 96380 |
|
23 |
23 |
$315.82 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
670 |
388 |
$312.84 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,481 |
794 |
$311.13 |
| 99251 |
|
14 |
12 |
$306.75 |
| 88300 |
|
474 |
391 |
$305.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,291 |
5,820 |
$303.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
689 |
474 |
$298.56 |
| 82164 |
|
26 |
26 |
$293.05 |
| 87106 |
|
12 |
12 |
$290.25 |
| A4648 |
Tissue marker, implantable, any type, each |
317 |
281 |
$284.23 |
| 84478 |
|
53 |
24 |
$278.40 |
| 80179 |
|
822 |
683 |
$275.14 |
| 82542 |
|
30 |
28 |
$272.12 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
41 |
39 |
$267.86 |
| 87075 |
|
283 |
231 |
$258.35 |
| A0130 |
Non-emergency transportation: wheelchair van |
15 |
12 |
$256.20 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,502 |
1,205 |
$255.90 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,131 |
882 |
$252.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,824 |
5,411 |
$250.52 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
575 |
496 |
$250.36 |
| 80202 |
|
20 |
12 |
$224.43 |
| 51702 |
|
60 |
51 |
$218.65 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,385 |
1,121 |
$215.22 |
| 84244 |
|
17 |
12 |
$214.11 |
| 36416 |
|
464 |
416 |
$210.51 |
| 82653 |
|
13 |
13 |
$209.41 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,050 |
3,271 |
$208.17 |
| 84300 |
|
91 |
75 |
$205.59 |
| 82365 |
|
24 |
16 |
$202.67 |
| 83010 |
|
16 |
13 |
$202.09 |
| 51701 |
|
512 |
461 |
$200.19 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,567 |
597 |
$194.91 |
| 87140 |
|
19 |
16 |
$194.33 |
| 82272 |
|
60 |
52 |
$192.27 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,028 |
5,834 |
$189.38 |
| 96411 |
|
31 |
14 |
$188.25 |
| 82274 |
|
16 |
12 |
$178.06 |
| 84155 |
|
1,558 |
1,330 |
$171.99 |
| 85670 |
|
184 |
168 |
$167.94 |
| 80178 |
|
17 |
12 |
$167.22 |
| 87110 |
|
19 |
16 |
$156.69 |
| 80183 |
|
12 |
12 |
$151.71 |
| 84446 |
|
13 |
12 |
$143.03 |
| 86645 |
|
12 |
12 |
$140.59 |
| 73660 |
|
25 |
25 |
$132.39 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
384 |
310 |
$131.63 |
| 86381 |
|
14 |
14 |
$126.24 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,491 |
1,718 |
$125.89 |
| 82390 |
|
12 |
12 |
$107.61 |
| 85520 |
|
58 |
26 |
$102.67 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,790 |
1,292 |
$93.27 |
| 29105 |
|
15 |
14 |
$93.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
59 |
29 |
$90.56 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,878 |
1,807 |
$80.07 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,380 |
695 |
$77.29 |
| J2060 |
Injection, lorazepam, 2 mg |
549 |
421 |
$63.08 |
| 92227 |
|
15 |
12 |
$61.22 |
| 94760 |
|
1,828 |
1,541 |
$59.98 |
| J1940 |
Injection, furosemide, up to 20 mg |
328 |
193 |
$58.70 |
| J7999 |
Compounded drug, not otherwise classified |
1,177 |
1,059 |
$58.05 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
733 |
384 |
$57.19 |
| 69210 |
|
44 |
39 |
$52.95 |
| 82945 |
|
14 |
12 |
$49.37 |
| S0209 |
Wheelchair van, mileage, per mile |
15 |
12 |
$43.41 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
258 |
212 |
$42.21 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,202 |
969 |
$39.44 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
282 |
238 |
$37.78 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
272 |
151 |
$35.29 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
768 |
645 |
$34.79 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
316 |
157 |
$34.20 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
178 |
49 |
$33.58 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
15 |
15 |
$31.68 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
90 |
72 |
$31.24 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
252 |
226 |
$30.86 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
117 |
66 |
$28.82 |
| 83930 |
|
14 |
12 |
$25.86 |
| J1836 |
Injection, metronidazole, 10 mg |
447 |
204 |
$24.94 |
| 88302 |
|
256 |
197 |
$22.65 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
19 |
12 |
$21.76 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
954 |
852 |
$20.82 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
116 |
92 |
$20.75 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
30 |
25 |
$19.00 |
| 85347 |
|
47 |
36 |
$15.98 |
| 91301 |
|
1,392 |
1,249 |
$11.89 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
22 |
12 |
$11.80 |
| J1953 |
Injection, levetiracetam, 10 mg |
38 |
30 |
$10.82 |
| 88720 |
|
15 |
14 |
$10.75 |
| 88173 |
|
18 |
12 |
$9.92 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
521 |
467 |
$9.33 |
| 99441 |
|
13 |
12 |
$9.29 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
528 |
285 |
$9.08 |
| 73600 |
|
13 |
13 |
$8.45 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,969 |
1,715 |
$8.03 |
| 91300 |
|
888 |
757 |
$7.36 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
388 |
258 |
$7.10 |
| J1630 |
Injection, haloperidol, up to 5 mg |
226 |
193 |
$6.98 |
| C1729 |
Catheter, drainage |
677 |
533 |
$5.94 |
| 91307 |
|
583 |
566 |
$5.63 |
| J3411 |
Injection, thiamine hcl, 100 mg |
108 |
49 |
$4.53 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
113 |
111 |
$2.89 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
306 |
102 |
$2.69 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
690 |
505 |
$2.50 |
| 91308 |
|
275 |
210 |
$2.28 |
| J1790 |
Injection, droperidol, up to 5 mg |
59 |
56 |
$2.20 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
170 |
80 |
$1.96 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
298 |
259 |
$1.26 |
| 91312 |
|
83 |
66 |
$0.77 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
19 |
15 |
$0.67 |
| J2372 |
Injection, phenylephrine hydrochloride (biorphen), 20 micrograms |
131 |
101 |
$0.56 |
| 91315 |
|
52 |
41 |
$0.50 |
| 91317 |
|
54 |
44 |
$0.46 |
| 91303 |
|
39 |
39 |
$0.35 |
| 91306 |
|
31 |
31 |
$0.30 |
| 91305 |
|
60 |
59 |
$0.19 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
788 |
569 |
$0.00 |
| C1776 |
Joint device (implantable) |
141 |
126 |
$0.00 |
| 76376 |
|
163 |
152 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
28 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
102 |
93 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
433 |
390 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
311 |
250 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
233 |
195 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
118 |
44 |
$0.00 |
| C1758 |
Catheter, ureteral |
320 |
256 |
$0.00 |
| J7070 |
Infusion, d5w, 1000 cc |
625 |
216 |
$0.00 |
| 90380 |
|
20 |
20 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
30 |
14 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
17 |
14 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
14 |
13 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
66 |
12 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
31 |
29 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
56 |
55 |
$0.00 |
| 96402 |
|
18 |
13 |
$0.00 |
| 95874 |
|
63 |
48 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
69 |
14 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
13 |
12 |
$0.00 |
| 88313 |
|
13 |
13 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
328 |
267 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
382 |
306 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
191 |
153 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
131 |
121 |
$0.00 |
| 84436 |
|
15 |
15 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
116 |
83 |
$0.00 |
| 00126 |
|
303 |
238 |
$0.00 |
| 80050 |
General health panel |
136 |
135 |
$0.00 |
| 94761 |
|
1,021 |
574 |
$0.00 |
| 88311 |
|
14 |
13 |
$0.00 |
| C1781 |
Mesh (implantable) |
141 |
116 |
$0.00 |
| 86141 |
|
15 |
15 |
$0.00 |
| 76377 |
|
191 |
165 |
$0.00 |
| 77001 |
|
138 |
118 |
$0.00 |
| 84479 |
|
15 |
15 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
16 |
13 |
$0.00 |
| 83090 |
|
15 |
15 |
$0.00 |
| 90381 |
|
15 |
15 |
$0.00 |